1
|
Kharaishvili G, Simkova D, Makharoblidze
E, Trtkova K, Kolar Z and Bouchal J: Wnt signaling in prostate
development and carcinogenesis. Biomed Pap Med Fac Univ Palacky
Olomouc Czech Repub. 155:11–18. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kumamoto H and Ooya K: Immunohistochemical
detection of beta-catenin and adenomatous polyposis coli in
ameloblastomas. Oral Pathol Med. 34:401–406. 2005. View Article : Google Scholar
|
3
|
Peng L, Ye L, Dong G, Ren LB, Wang CL, Xu
P and Zhou XD: WNT5A inhibits human dental papilla cell
proliferation and migration. Biochem Biophys Res Commun.
390:1072–1078. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Barnes L, Eveson JW, Reichart P and
Sidransky D: Pathology and Genetics of Head and Neck Tumours. World
Health Organization Classification of Tumours. IARC Press; Lyon;
2006
|
5
|
Li TJ, Wu YT, Yu SF and Yu GF: Unicystic
ameloblastoma: A clinicopathologic study of 33 Chinese patients. Am
J Surg Pathol. 24:1385–1392. 2000. View Article : Google Scholar : PubMed/NCBI
|
6
|
Grintzalis K, Georgiou CD and Schneider
YJ: An accurate and sensitive Coomassie brilliant blue G-250-based
assay for protein determination. Anal Biochem. 480:28–30. 2015.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Howe LR, Subbaramaiah K, Chung WJ,
Dannenberg AJ and Brown AM: Transcriptional activation of
cyclooxygenase-2 in Wnt-1 transformed mouse mammary epithelial
cells. Cancer Res. 59:1572–1577. 1999.PubMed/NCBI
|
10
|
Yoshida N, Kinugasa T, Ohshima K, Yuge K,
Ohchi T, Fujino S, Shiraiwa S, Katagiri M and Akagi Y: Analysis of
Wnt and β-catenin expression in advanced colorectal cancer.
Anticancer Res. 35:4403–4410. 2015.PubMed/NCBI
|
11
|
Wittkorn E, Sarkar A, Garcia K,
Kango-Singh M and Singh A: The Hippo pathway effector Yki
downregulates Wg signaling to promote retinal differentiation in
the Drosophila eye. Developmental. 142:2002–2013. 2015. View Article : Google Scholar
|
12
|
Liu B, Chen S, Cheng D, Jing W and Helms
JA: Primary cilia integrate hedgehog and Wnt signaling during tooth
development. J Dent Res. 93:475–482. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Maasalu K, Nikopensius T, Kõks S, Nõukas
M, Kals M, Prans E, Zhytnik L, Metspalu A and Märtson A:
Whole-exome sequencing identifies de novo mutation in the COL1A1
gene to underlie the severe osteogenesis imperfecta. Hum Genomics.
9:62015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Katoh M: Expression and regulation of Wnt1
in human cancer: Upregulation of Wnt1 by β-estradiol in MCF-7
cells. Int J Oncol. 22:209–212. 2003.PubMed/NCBI
|
15
|
Jia J, Jia S, Ji K and Jiang WG: Wnt1
inducible signalling pathway protein-2 (WISP-2/CCN5): Roles and
regulation in human cancers (Review). Oncol Rep. 31:533–539. 2014.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Choi AR, Park JR, Kim RJ, Kim SR, Cho SD,
Jung JY and Nam JS: Inhibition of Wnt1 expression reduces the
enrichment of cancer stem cells in a mouse model of breast cancer.
Biochem Biophys Res Commun. 425:436–442. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Keupp K, Beleggia F, Kayserili H, Barnes
AM, Steiner M, Semler O, Fischer B, Yigit G, Janda CY, Becker J, et
al: Mutations in WNT1 cause different forms of bone fragility. Am J
Hum Genet. 92:565–574. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Joeng KS, Lee YC, Jiang MM, Bertin TK,
Chen Y, Abraham AM, Ding H, Bi X, Ambrose CG and Lee BH: The
swaying mouse as a model of osteogenesis imperfecta caused by WNT1
mutations. Hum Mol Genet. 23:4035–4042. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kato K, Nakatani Y, Kanno H, Inayama Y,
Ijiri R, Nagahara N, Miyake T, Tanaka M, Ito Y, Aida N, et al:
Possible linkage between specific histological structures and
aberrant reactivation of Wnt pathway in adamantinomatous
craniopharyngioma. J Pathol. 203:814–821. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Fuchs-Young R, Shirley SH, Lambertzl I,
Colby JK, Tian J, Johnston D, Gimenez-Conti IB, Donehower LA, Conti
CJ and Hursting SD: P53 genotype as a determinant of ER expression
and tamoxifen response in the MMTV-Wnt-1 model of mammary
carcinogenesis. Breast Cancer Res Treat. 130:399–408. 2011.
View Article : Google Scholar : PubMed/NCBI
|